Recently, Shanghai Duoning Biotechnology Co., Ltd. ("Duoning") was select as a "Science and Technology Little Giant Enterprise for Cultivation", which proves the company's independent innovation power, R&D capability and the ability for sustainable development.

(Source: STCSM)

Under the joint direction of the Science and Technology Commission of Shanghai Municipality (STCSM), Shanghai Municipal Commission of Economy and Informatization and Shanghai Municipal Finance Bureau, the Science and Technology Little Giant Project is designed for innovative, large-scale and exemplary enterprises. The candidate will be appraised based on multiple dimensions such as the innovation system.

Duoning started its business in the field of cell culture media and now it has developed into a leading one-stop bioprocess solution provider in China with a whole set of products and services covering the entire bioprocess. Duoning has formed technological barriers in such fields as cell culture media, disposable consumables, bioreactors, nano-drug preparation systems, chromatography fillers and laboratory water purification systems.

As of June 30, 2022, Duoning has approximately 100 R&D personnel, about 200 patents and an international sales network, and can offer more than 200 products and over 70 kinds of services.

In the future, Duoning will be innovation-driven to further independent research and seek high-quality development featured a complete biopharmaceutical supply chain to help China's biotechnology industry walk at the forefront of the world with innovative technologies.

About Duoning

Founded in 2005, Shanghai Duoning Biotechnology Co., Ltd. is dedicated to providing one-stop solutions for biopharmaceutical customers, including products and services for biologics products research, development and commercialization. For more information, please visit: m.kstgo.com.

Contacts:

Media: PR@duoningbio.com